Shire PLC’s success in defeating hedge fund manager Kyle Bass’ attempt to invalidate its Lialda (mesalamine) patent may bode well for other companies facing inter partes review challenges to their patents.
The Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) issued a final written decision on Oct....





